Adaptive Biotechnologies (ADPT) EBIT Growth (1y) (2019 - 2026)
Adaptive Biotechnologies (ADPT) EBIT Growth (1y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.44 Bn | 209.37 Bn | 8.34 Bn | 13.79% |
| 2 | Danaher | 139.95 Bn | 135.60 Bn | 3.61 Bn | 48.29% |
| 3 | Idexx Laboratories | 46.16 Bn | 45.96 Bn | 779.09 Mn | 14.08% |
| 4 | Agilent Technologies | 39.67 Bn | 37.87 Bn | 990.00 Mn | 33.00% |
| 5 | Iqvia Holdings | 39.29 Bn | 37.21 Bn | 1.44 Bn | 0.00% |
| 6 | Natera | 38.61 Bn | 37.51 Bn | 696.04 Mn | -18.11% |
| 7 | Illumina | 29.99 Bn | 28.82 Bn | 770.00 Mn | 14.49% |
| 8 | Mettler Toledo International | 28.57 Bn | 28.51 Bn | 650.22 Mn | 17.41% |
| 9 | Quest Diagnostics | 26.17 Bn | 25.55 Bn | 1.03 Bn | 4.79% |
| 10 | Adaptive Biotechnologies | 3.78 Bn | 3.56 Bn | 52.17 Mn | 35.12% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 35.12% |
| Dec 31, 2025 | 62.25% |
| Sep 30, 2025 | 131.53% |
| Jun 30, 2025 | 47.09% |
| Mar 31, 2025 | 39.29% |
| Dec 31, 2024 | 52.39% |
| Sep 30, 2024 | 35.96% |
| Jun 30, 2024 | 1.05% |
| Mar 31, 2024 | 14.74% |
| Dec 31, 2023 | -81.36% |
| Sep 30, 2023 | -12.16% |
| Jun 30, 2023 | 8.92% |
| Mar 31, 2023 | 9.31% |
| Dec 31, 2022 | 36.38% |
| Sep 30, 2022 | 19.34% |
| Jun 30, 2022 | -5.50% |
| Mar 31, 2022 | -52.78% |
| Dec 31, 2021 | -39.23% |
| Sep 30, 2021 | -52.03% |
| Jun 30, 2021 | -34.83% |